NPI: 1104871573 · JACKSON, MS 39204 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,512 | $394K |
| 2019 | 18,103 | $361K |
| 2020 | 15,727 | $210K |
| 2021 | 11,984 | $168K |
| 2022 | 11,736 | $233K |
| 2023 | 6,833 | $328K |
| 2024 | 3,451 | $320K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,988 | 2,796 | $1.50M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,491 | 1,694 | $334K |
| A4657 | Syringe, with or without needle, each | 4,256 | 2,128 | $47K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 354 | 199 | $46K |
| 83970 | 1,438 | 1,261 | $36K | |
| J1756 | Injection, iron sucrose, 1 mg | 5,843 | 1,665 | $19K |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,892 | 1,537 | $7K |
| 82728 | 655 | 603 | $6K | |
| 85045 | 1,422 | 1,020 | $4K | |
| 83550 | 514 | 481 | $4K | |
| 83540 | 672 | 611 | $3K | |
| 85041 | 1,486 | 1,315 | $3K | |
| 85048 | 1,456 | 1,291 | $2K | |
| 82108 | 72 | 70 | $1K | |
| 90674 | 41 | 32 | $535.10 | |
| 82746 | 25 | 25 | $325.21 | |
| 90747 | 13 | 13 | $310.31 | |
| 90732 | 15 | 12 | $228.42 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,085 | 750 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 15 | 12 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 54 | 46 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 559 | 313 | $0.00 |